Trials / Completed
CompletedNCT02449486
Ropivacaine After Sternotomy
Ropivacaine Infusion to Alleviate Postoperative Pain After Cardiac Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Kuopio University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Continuous ropivacaine infusion to sternotomy wound after coronary artery bypass grafting (CABG) or heart valve surgery to diminish postoperative pain.
Detailed description
A multiporous catheter will be introduced into sternotomy wound to CABG or heart valve surgery patients and continuous ropivacaine infusion 4 ml/h will be started immediately after surgery. Ropivacaine infusion will be administered during 48 postoperative hours. All patients receive patient controlled analgesia (PCA) oxycodone after extubation in the PACU. All patients receive a standardized anesthesia during surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-05-20
- Last updated
- 2018-04-24
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02449486. Inclusion in this directory is not an endorsement.